Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Sarcopenia in Patients With Idiopathic Pulmonary Fibrosis
A clinical trial evaluating sarcopenia in patients with idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
A Phase 3 trial evaluating BI 1015550 for improving lung function in idiopathic pulmonary fibrosis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Prognostic Score Comparison in IPF and HP
A completed clinical trial compares prognostic scoring methods in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis (interstiti…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib
A clinical trial update from Taiwan reports long-term outcomes for people with progressive fibrosing interstitial lung diseases who started …
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis [Phase 3]
Phase 3 multinational trial evaluating the efficacy and safety of inhaled treprostinil in idiopathic pulmonary fibrosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD). [Phase 1]
Phase 1 study in idiopathic pulmonary fibrosis assessed safety, tolerability, and pharmacokinetics of a monoclonal antibody. The trial is co…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF [Phase 1]
A Phase 1 PET imaging study of PIPE-791 in healthy volunteers and individuals with idiopathic pulmonary fibrosis and multiple sclerosis has …
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 randomized, double-blind study of Bexotegrast (PLN-74809) for idiopathic pulmonary fibrosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients [Phase 1]
A Phase 1 trial evaluating the investigational therapy LTI-03 in newly diagnosed Idiopathic Pulmonary Fibrosis has completed enrollment and …
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Dose Reduction and Discontinuation With Anti-Fibrotic Medications
A completed Boehringer Ingelheim trial update evaluating dose reduction and discontinuation patterns with anti-fibrotic therapy in idiopathi…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: IPF mHealth Exercise Study [NA]
A completed clinical trial from the University of Washington evaluating an mHealth-based exercise program for idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Cough Reduction in IPF With Nalbuphine ER [Phase 2]
Trevi Therapeutics completed a Phase 2 trial of nalbuphine extended-release for cough reduction in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib
A completed medical-records study in Spain assessed diarrhea management in patients with idiopathic pulmonary fibrosis treated with nintedan…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: The Effectiveness of Pulmonary Rehabilitation on Saturation in Patients With Idiopathic Pulmonary Fibrosis [NA]
A completed clinical trial assessing the effectiveness of pulmonary rehabilitation on oxygen saturation in patients with idiopathic pulmonar…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
This clinical trial update notes a Phase 2 long-term safety and efficacy study of HSK44459 tablets in idiopathic pulmonary fibrosis, with re…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Londrina Activities of Daily Living Protocol in Idiopathic Pulmonary Fibrosis Patients
A clinical trial evaluating a Londrina Activities of Daily Living protocol in patients with idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough [Phase 2]
Phase 2 study evaluating nalbuphine extended-release for cough in idiopathic pulmonary fibrosis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF [Phase 2]
Phase 2 trial evaluating safety, efficacy, and pharmacokinetics of C21 in idiopathic pulmonary fibrosis has completed and results have been …
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: The Effect Of Baduanjin Exercises In Patients With Idiopathic Pulmonary Fibrosis [NA]
This clinical trial update reports the completion of a study evaluating the effect of Baduanjin exercises in patients with idiopathic pulmon…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF) [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of ME-015 (suplatast tosilate) for cough associated with idiopathic pulmonary fibr…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: A Study of Patients With Chronic Disease
Clinical trial update indicates the study NCT04263727 involving patients with chronic respiratory diseases has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF [Phase 2]
Phase 2 clinical trial update showing completion of a study evaluating the efficacy, safety, and tolerability of BBT-877 in patients with id…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 trial evaluating intravenous SHR-1906 for idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: An Atlas of Airways at a Single Cell Level in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Controls [NA]
A completed clinical trial studying a single-cell atlas of airways in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosi…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions [Phase 1]
A completed Phase 1 pharmacokinetic study evaluating pirfenidone modified-release tablets in healthy volunteers under fasting and fed condit…